The Prokinetic drugs Market is expected to register a CAGR of 4.4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Prokinetic Drugs market report is segmented by type into Metoclopramide, Domperidone, and Cisapride. The application segment includes Gastroparesis, Constipation, Reflux Esophagitis, and Functional Dyspepsia. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Prokinetic drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Prokinetic drugs Market Segmentation
Type- Metoclopramide
- Domperidone
- Cisapride
- Gastroparesis
- Constipation
- Reflux Esophagitis
- Functional Dyspepsia
Strategic Insights
Prokinetic drugs Market Growth Drivers- Rising Prevalence of Gastrointestinal Disorders: The increasing incidence of gastrointestinal disorders, including gastroparesis, irritable bowel syndrome, and functional dyspepsia, is a key driver of the Prokinetic Drugs Market.
- Aging Population and Age-Related Digestive Issues: The growing geriatric population, with its higher susceptibility to digestive problems, continues to contribute significantly to market growth.The continuously increasing geriatric population with age-related digestive issues continues to fuel the growth of this market.
- Increased Awareness and Demand: Rising awareness regarding the benefits of prokinetic drugs in managing gastrointestinal disorders is further increasing their demand among healthcare professionals and patients.
- Personalized Medicine: One significant trend is the growing focus on personalized drugs, tailored to meet the specific needs of individual patients. Advancements in genomics and proteomics have paved the way for therapies that target the underlying causes of gastrointestinal (GI) disorders at a molecular level. These personalized treatments offer more effective and precise management of GI conditions, enhancing the overall success rate of therapy.
- Integration of Herbal and Dietary Supplements: Another trend gaining momentum is the inclusion of herbal and dietary supplements as adjuncts to prokinetic drugs. As interest in natural and alternative medicine continues to rise, these supplements are increasingly seen as effective complements to modern pharmaceuticals. The growing acceptance of alternative remedies, coupled with advanced diagnostic techniques, is driving the demand for integrative approaches to gastrointestinal care.
- Advances in Gastrointestinal Research: Recent advancements in the understanding of gastrointestinal physiology and pathophysiology have opened doors to the development of new drugs aimed at optimizing GI therapy. These new research avenues are focused on creating prokinetic drugs with better safety profiles, improved efficacy, and fewer side effects, further strengthening the market outlook.
- Personalized Medicine: A key trend shaping the Prokinetic Drugs Market is the growing emphasis on personalized medicine. Advances in genomics and proteomics allow for the development of drugs specifically designed to target the underlying causes of gastrointestinal (GI) disorders. These tailored therapies provide more precise, effective treatment options, addressing individual patient needs and significantly improving treatment outcomes.
- Personalized Medicine: A key trend shaping the Prokinetic Drugs Market is the growing emphasis on personalized medicine. Advances in genomics and proteomics allow for the development of drugs specifically designed to target the underlying causes of gastrointestinal (GI) disorders. These tailored therapies provide more precise, effective treatment options, addressing individual patient needs and significantly improving treatment outcomes.
- Focus on Combination Therapies: Another notable trend in the market is the growing interest in combination therapies. By integrating prokinetic drugs with other therapeutic agents, pharmaceutical companies aim to offer more comprehensive solutions to patients suffering from complex GI disorders. These combination therapies may enhance the effectiveness of treatment while minimizing side effects, presenting a promising avenue for market growth.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Prokinetic drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Prokinetic drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The leading players of the market are: Johnson and Johnson, Sanofi S.A., Cadila Pharmaceuticals., Hanmi Pharm Co., Ltd., Kyowa Kirin Co., Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Medley Pharmaceuticals Ltd, Sumitomo Dainippon Pharma Co., Ltd. (Sumitomo Chemical), Tranzyme Pharma, Inc.
Several emerging trends shape the future of the Prokinetic Drugs Market. Personalized medicine, based on the genomics and proteomics of patients, is giving a boost to targeted therapy. Digital health technologies that include wearable devices and telemedicine allow remote patient monitoring and personalized treatment plans. The growing interest in natural and alternative therapies is stimulating development in herbal and dietary supplements with prokinetic properties. In addition, advancements in drug delivery systems and nanotechnology are improving the efficacy of drugs and reducing side effects. This trend together is making a promising future for the Prokinetic Drugs Market.
Prokinetic drugs Market is expected to grow at a CAGR of 4.4% between 2023-2031
Several factors drive the Prokinetic Drugs Market, including the increasing incidence of gastrointestinal disorders such as gastroparesis, irritable bowel syndrome, and functional dyspepsia. An aging population and a rise in healthcare spending are also significant factors. Other drivers include advances in drug development, including targeted therapies and personalized medicine, that provide new options for treatment. Awareness of these drugs and their benefits, along with favorable regulatory environments, also open up huge opportunities for growth in the market.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prokinetic Drugs Market - By Type
1.3.2 Prokinetic Drugs Market - By Application
1.3.3 Prokinetic Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROKINETIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROKINETIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROKINETIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PROKINETIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. PROKINETIC DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PROKINETIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. METOCLOPRAMIDE
7.3.1. Overview
7.3.2. Metoclopramide Market Forecast and Analysis
7.4. DOMPERIDONE
7.4.1. Overview
7.4.2. Domperidone Market Forecast and Analysis
7.5. CISAPRIDE
7.5.1. Overview
7.5.2. Cisapride Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. PROKINETIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTROPARESIS
8.3.1. Overview
8.3.2. Gastroparesis Market Forecast and Analysis
8.4. CONSTIPATION
8.4.1. Overview
8.4.2. Constipation Market Forecast and Analysis
8.5. REFLUX ESOPHAGITIS
8.5.1. Overview
8.5.2. Reflux Esophagitis Market Forecast and Analysis
8.6. FUNCTIONAL DYSPEPSIA
8.6.1. Overview
8.6.2. Functional Dyspepsia Market Forecast and Analysis
9. PROKINETIC DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Prokinetic Drugs Market Overview
9.1.2 North America Prokinetic Drugs Market Forecasts and Analysis
9.1.3 North America Prokinetic Drugs Market Forecasts and Analysis - By Type
9.1.4 North America Prokinetic Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Prokinetic Drugs Market
9.1.5.1.1 United States Prokinetic Drugs Market by Type
9.1.5.1.2 United States Prokinetic Drugs Market by Application
9.1.5.2 Canada Prokinetic Drugs Market
9.1.5.2.1 Canada Prokinetic Drugs Market by Type
9.1.5.2.2 Canada Prokinetic Drugs Market by Application
9.1.5.3 Mexico Prokinetic Drugs Market
9.1.5.3.1 Mexico Prokinetic Drugs Market by Type
9.1.5.3.2 Mexico Prokinetic Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Prokinetic Drugs Market Overview
9.2.2 Europe Prokinetic Drugs Market Forecasts and Analysis
9.2.3 Europe Prokinetic Drugs Market Forecasts and Analysis - By Type
9.2.4 Europe Prokinetic Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Prokinetic Drugs Market
9.2.5.1.1 Germany Prokinetic Drugs Market by Type
9.2.5.1.2 Germany Prokinetic Drugs Market by Application
9.2.5.2 France Prokinetic Drugs Market
9.2.5.2.1 France Prokinetic Drugs Market by Type
9.2.5.2.2 France Prokinetic Drugs Market by Application
9.2.5.3 Italy Prokinetic Drugs Market
9.2.5.3.1 Italy Prokinetic Drugs Market by Type
9.2.5.3.2 Italy Prokinetic Drugs Market by Application
9.2.5.4 Spain Prokinetic Drugs Market
9.2.5.4.1 Spain Prokinetic Drugs Market by Type
9.2.5.4.2 Spain Prokinetic Drugs Market by Application
9.2.5.5 United Kingdom Prokinetic Drugs Market
9.2.5.5.1 United Kingdom Prokinetic Drugs Market by Type
9.2.5.5.2 United Kingdom Prokinetic Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Prokinetic Drugs Market Overview
9.3.2 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Prokinetic Drugs Market
9.3.5.1.1 Australia Prokinetic Drugs Market by Type
9.3.5.1.2 Australia Prokinetic Drugs Market by Application
9.3.5.2 China Prokinetic Drugs Market
9.3.5.2.1 China Prokinetic Drugs Market by Type
9.3.5.2.2 China Prokinetic Drugs Market by Application
9.3.5.3 India Prokinetic Drugs Market
9.3.5.3.1 India Prokinetic Drugs Market by Type
9.3.5.3.2 India Prokinetic Drugs Market by Application
9.3.5.4 Japan Prokinetic Drugs Market
9.3.5.4.1 Japan Prokinetic Drugs Market by Type
9.3.5.4.2 Japan Prokinetic Drugs Market by Application
9.3.5.5 South Korea Prokinetic Drugs Market
9.3.5.5.1 South Korea Prokinetic Drugs Market by Type
9.3.5.5.2 South Korea Prokinetic Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Prokinetic Drugs Market Overview
9.4.2 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Prokinetic Drugs Market
9.4.5.1.1 South Africa Prokinetic Drugs Market by Type
9.4.5.1.2 South Africa Prokinetic Drugs Market by Application
9.4.5.2 Saudi Arabia Prokinetic Drugs Market
9.4.5.2.1 Saudi Arabia Prokinetic Drugs Market by Type
9.4.5.2.2 Saudi Arabia Prokinetic Drugs Market by Application
9.4.5.3 U.A.E Prokinetic Drugs Market
9.4.5.3.1 U.A.E Prokinetic Drugs Market by Type
9.4.5.3.2 U.A.E Prokinetic Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Prokinetic Drugs Market Overview
9.5.2 South and Central America Prokinetic Drugs Market Forecasts and Analysis
9.5.3 South and Central America Prokinetic Drugs Market Forecasts and Analysis - By Type
9.5.4 South and Central America Prokinetic Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Prokinetic Drugs Market
9.5.5.1.1 Brazil Prokinetic Drugs Market by Type
9.5.5.1.2 Brazil Prokinetic Drugs Market by Application
9.5.5.2 Argentina Prokinetic Drugs Market
9.5.5.2.1 Argentina Prokinetic Drugs Market by Type
9.5.5.2.2 Argentina Prokinetic Drugs Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PROKINETIC DRUGS MARKET, KEY COMPANY PROFILES
11.1. JOHNSON AND JOHNSON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANOFI S.A.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CADILA PHARMACEUTICALS.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. HANMI PHARM.CO.,LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. KYOWA KIRIN CO., LTD.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MEDLEY PHARMACEUTICALS LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUMITOMO DAINIPPON PHARMA CO., LTD.(SUMITOMO CHEMICAL)
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TRANZYME PHARMA, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Johnson and Johnson
2. Sanofi S.A.
3. Cadila Pharmaceuticals.
4. Hanmi Pharm.Co.,Ltd.
5. Kyowa Kirin Co., Ltd.
6. Pfizer Inc.
7. Teva Pharmaceutical Industries Ltd.
8. Medley Pharmaceuticals Ltd
9. Sumitomo Dainippon Pharma Co., Ltd.(Sumitomo Chemical)
10. Tranzyme Pharma, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For